A meta-analysis of mortality and coronary prevention in hypertensive patients treated with beta-receptor blockers.
Shinton R A, Beevers D G·Journal of human hypertension
As beta-adrenoreceptor blockers have been shown to reduce mortality following myocardial infarction by around 20%, a similar pattern of 'cardioprotection' was looked for in hypertensive patients. Several non-randomised retrospective studies have suggested that beta-blockers may reduce either the mortality or morbidity…